Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jun 16, 2026

Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery
11:49

Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery

Published on: April 3, 2026

Controversies surrounding lymph node dissection for prostate cancer.

Ganesh S Palapattu1, Eric A Singer, Edward M Messing

  • 1Department of Urology, The Methodist Hospital, 6560 Fannin, Suite 2100, Houston, TX 77030, USA. gpalapattu@tmhs.org

The Urologic Clinics of North America
|February 16, 2010
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Insulin Pathway Changes in Localized Prostate Cancer: A Multi-Institutional Analysis.

Cancers·2026
Same author

A risk-adapted approach to reTURBT in high-grade T1 NMIBC.

Bladder cancer (Amsterdam, Netherlands)·2026
Same author

Understanding what surgical advanced practice providers want: A survey of autonomy, tasks, and training preferences across three institutions.

American journal of surgery·2026
Same author

Perioperative therapies for metastatic renal cell carcinoma.

Journal of cancer metastasis and treatment·2026
Same author

Using ctDNA to Inform Adjuvant Therapy for Urologic Malignancies.

Cancers·2026
Same author

Clinical management of oligoprogressive renal cell carcinoma.

Expert review of anticancer therapy·2026
Same journal

An Unprecedented Era of Innovation in Non-Muscle-Invasive Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Hubert Humphrey's Bladder Cancer: If He Could Have Time Traveled, Would that Have Changed the Outcome?

The Urologic clinics of North America·2026
Same journal

Key Clinical Trials Shaping the Future of Superficial High-Risk Bladder Cancer Management.

The Urologic clinics of North America·2026
Same journal

Future Directions: Artificial Intelligence and Digital Tools in Bladder Cancer Care.

The Urologic clinics of North America·2026
Same journal

Economic Considerations in the Management of Superficial Bladder Cancer.

The Urologic clinics of North America·2026
Same journal

Patient-Centered Approaches to Non-Muscle-Invasive Bladder Cancer Care.

The Urologic clinics of North America·2026
See all related articles

Radical prostatectomy for prostate cancer may benefit from pelvic lymph node dissection. This review analyzes the pros, cons, and implications, highlighting the need for more clinical trials.

Area of Science:

  • Urology
  • Oncology

Background:

  • Radical prostatectomy is a common treatment for prostate cancer.
  • The role of pelvic lymph node dissection (PLND) during radical prostatectomy remains debated.
  • Key uncertainties involve patient selection and optimal surgical extent.

Purpose of the Study:

  • To discuss the advantages and disadvantages of PLND in prostate cancer surgery.
  • To explore the staging, diagnostic, and therapeutic implications of PLND.
  • To review existing data due to a lack of randomized clinical trials.

Main Methods:

  • Analysis of retrospective data.
  • Review of case series.
  • Discussion of current literature and clinical uncertainties.

More Related Videos

Murine Mesenteric Lymphadenectomy for Selective Disruption of Lymphatic Communication with Region-Specific Gut
07:27

Murine Mesenteric Lymphadenectomy for Selective Disruption of Lymphatic Communication with Region-Specific Gut

Published on: December 30, 2025

Related Experiment Videos

Last Updated: Jun 16, 2026

Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery
11:49

Single-port Non-liposuction Endoscopic Axillary Lymph Node Dissection in Breast Cancer Surgery

Published on: April 3, 2026

Murine Mesenteric Lymphadenectomy for Selective Disruption of Lymphatic Communication with Region-Specific Gut
07:27

Murine Mesenteric Lymphadenectomy for Selective Disruption of Lymphatic Communication with Region-Specific Gut

Published on: December 30, 2025

Main Results:

  • PLND provides staging and potential therapeutic benefits in select prostate cancer patients.
  • The optimal surgical template and patient selection criteria require further definition.
  • Current evidence is largely derived from non-randomized studies.

Conclusions:

  • PLND is a critical component for accurate prostate cancer staging and management.
  • Further high-quality research, including randomized trials, is needed to definitively establish optimal PLND guidelines.
  • Careful consideration of patient factors and surgical extent is essential when deciding on PLND.